Department of Microbiology & Immunology, University of Melbourne, Grattan St, Parkville, Victoria 3010, Australia.
Semin Immunol. 2010 Apr;22(2):61-7. doi: 10.1016/j.smim.2009.10.004. Epub 2009 Nov 28.
alphabeta T cell receptors (TCRs) have traditionally been viewed as receptors for peptide antigens presented by either Major Histocompatibility Complex (MHC) class I (for CD8 T cells) or MHC class II (for CD4 T cells) antigen-presenting molecules. However, it is now clear that some T cell lineages express TCRs that are specialized for recognition of lipid-based antigens presented by the MHC class I-like CD1 family. Recently, the molecular basis for the TCR recognition of glycolipid antigens presented by CD1d has revealed an evolutionarily conserved-docking mode that is distinct from that of peptide-based recognition. T cells carrying these receptors follow a unique developmental pathway that results not only in unconventional antigen specificity, but also seemingly exaggerated functional capabilities, which makes these cells and their antigens highly attractive targets for immunotherapeutic manipulation.
alphabeta T 细胞受体 (TCRs) 传统上被认为是由主要组织相容性复合体 (MHC) 类 I(用于 CD8 T 细胞)或 MHC 类 II(用于 CD4 T 细胞)抗原呈递分子呈递的肽抗原的受体。然而,现在很清楚,一些 T 细胞谱系表达 TCR,这些 TCR 专门用于识别由 MHC 类 I 样 CD1 家族呈递的基于脂质的抗原。最近,TCR 识别 CD1d 呈递的糖脂抗原的分子基础揭示了一种进化上保守的对接模式,与基于肽的识别模式不同。携带这些受体的 T 细胞遵循一种独特的发育途径,不仅导致非传统的抗原特异性,而且似乎还具有夸张的功能能力,这使得这些细胞及其抗原成为免疫治疗操作的极具吸引力的目标。